Clinical Trial Update: Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating continuous apomorphine infusion for cognitive and neuropsychological outcomes in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: Rennes University Hospital | Conditions: Parkinsons's Disease | Phase 3 | Status: COMPLETED